Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report) shares gapped down prior to trading on Monday . The stock had previously closed at $129.94, but opened at $118.20. Pro Medicus shares last traded at $118.20, with a volume of 15 shares.
Analysts Set New Price Targets
Separately, Jefferies Financial Group downgraded Pro Medicus from a “buy” rating to a “hold” rating in a report on Wednesday, July 8th. One analyst has rated the stock with a Hold rating, According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $155.00.
Get Our Latest Report on PMCUF
Pro Medicus Stock Performance
About Pro Medicus
Pro Medicus Limited is an Australia?based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.
The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.
Featured Stories
- Five stocks we like better than Pro Medicus
- Birkenstock Beats the Skeptics—But Not on EPS
- D-Wave Has Momentum—What Does It Need to Keep It Going?
- TSMC’s Insider Buying Wave Comes With a Bigger AI Question for Investors
- Looking Beyond CrowdStrike? 3 AI Security Stocks Stand Out
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
